Product image of Vimizim (Elosulfase Alfa) supplied by GNH India

Vimizim

Active Ingredient:
Elosulfase Alfa
Origin:
EU

Vimizim (Elosulfase Alfa)

Vimizim (elosulfase alfa) is an enzyme replacement therapy for mucopolysaccharidosis type IVA (Morquio A syndrome). This prescription medication helps manage symptoms by replacing deficient enzymes. Suitable for patients with confirmed Morquio A diagnosis. Always consult a healthcare provider before use.

Manufacturer / TM Owner

Biomarin International Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Vimizim is used to treat mucopolysaccharidosis type IVA, also known as Morquio A syndrome. This rare genetic disorder affects the body's ability to break down certain sugars, leading to skeletal and systemic complications. Elosulfase alfa helps improve mobility and respiratory function in affected individuals. It is administered under medical supervision to ensure proper dosing and monitoring.

Side Effects

  • Patients receiving Vimizim may experience improved endurance and reduced fatigue over time. Some individuals report better mobility and breathing comfort after consistent treatment. The medication works gradually to address underlying enzyme deficiencies. Regular infusions are typically required to maintain therapeutic benefits.

Precautions & Warnings

  • Vimizim is administered intravenously in a clinical setting to monitor for infusion-related reactions. Patients should be observed for signs of hypersensitivity, including rash, fever, or breathing difficulties. Pre-treatment with antihistamines or corticosteroids may be recommended to minimize risks. Always disclose full medical history to your healthcare provider before starting therapy.

Avoid Interactions

  • Limited data exists on drug interactions with Vimizim. However, caution is advised when combining with other medications that affect the immune system or metabolism. Alcohol and certain supplements may influence treatment tolerance. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they are using.

References

Frequently Asked Questions

Vimizim is used to treat mucopolysaccharidosis type IVA (Morquio A syndrome), a rare genetic disorder affecting enzyme function.

Vimizim is given as an intravenous infusion in a healthcare setting, typically over several hours.

Common side effects may include fever, headache, nausea, or infusion-related reactions like rash or itching.

Vimizim must be administered by a healthcare professional in a clinical environment due to potential infusion reactions.

Vimizim helps manage symptoms but is not a cure for mucopolysaccharidosis type IVA (Morquio A syndrome).

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Elosulfase Alfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT